Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy

Niklas W. Andersson; Claus Zachariae; Anne B. Simonsen

doi:10.1016/j.ejca.2020.12.017

Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy

Niklas W. Andersson^*
, Claus Zachariae
, Anne B. Simonsen

^*Corresponding author af dette arbejde

Afdeling for Allergi, Hud- og Kønssygdomme HGH

6 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	European Journal of Cancer
Vol/bind	145
Sider (fra-til)	168-170
Antal sider	3
ISSN	0959-8049
DOI	https://doi.org/10.1016/j.ejca.2020.12.017
Status	Udgivet - mar. 2021

Adgang til dokumentet

10.1016/j.ejca.2020.12.017

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{96bc8f24f9744d0395aaebd447637bc2,

title = "Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy",

keywords = "Adrenal Cortex Hormones/therapeutic use, Antibodies, Monoclonal, Humanized/adverse effects, Antineoplastic Agents, Immunological/adverse effects, Carcinoma, Non-Small-Cell Lung/drug therapy, Drug Therapy, Combination, Female, Humans, Immune Checkpoint Inhibitors/adverse effects, Immunosuppressive Agents/therapeutic use, Lung Neoplasms/drug therapy, Lupus Erythematosus, Cutaneous/chemically induced, Middle Aged, Treatment Outcome",

author = "Andersson, \{Niklas W.\} and Claus Zachariae and Simonsen, \{Anne B.\}",

year = "2021",

month = mar,

doi = "10.1016/j.ejca.2020.12.017",

language = "English",

volume = "145",

pages = "168--170",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy

AU - Andersson, Niklas W.

AU - Zachariae, Claus

AU - Simonsen, Anne B.

PY - 2021/3

Y1 - 2021/3

KW - Adrenal Cortex Hormones/therapeutic use

KW - Antibodies, Monoclonal, Humanized/adverse effects

KW - Antineoplastic Agents, Immunological/adverse effects

KW - Carcinoma, Non-Small-Cell Lung/drug therapy

KW - Drug Therapy, Combination

KW - Female

KW - Humans

KW - Immune Checkpoint Inhibitors/adverse effects

KW - Immunosuppressive Agents/therapeutic use

KW - Lung Neoplasms/drug therapy

KW - Lupus Erythematosus, Cutaneous/chemically induced

KW - Middle Aged

KW - Treatment Outcome

UR - https://www.scopus.com/pages/publications/85099610779

U2 - 10.1016/j.ejca.2020.12.017

DO - 10.1016/j.ejca.2020.12.017

M3 - Letter

C2 - 33486439

AN - SCOPUS:85099610779

SN - 0959-8049

VL - 145

SP - 168

EP - 170

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -